Saturday 19 April 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Third Harmonic Bio
A biopharmaceutical company focused on developing next-in-class inflammatory disease medicines.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Biotechnology
Neurizon strengthens leadership team
18 April 2025
Biotechnology
Lilly deal a nod to BigHat’s AI-driven antibodies
17 April 2025
Biotechnology
Werewolf Therapeutics names Steven Bloom as CBO
17 April 2025
More ones to watch news >
Reset all filters
Refine Search
Opthea
Opthea
OncoZenge
OncoZenge
Axsome Therapeutics
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience


Today's issue

New Dupixent approval in the USA for CSU
Biotechnology
New Dupixent approval in the USA for CSU
19 April 2025
Biotechnology
Earendil Labs inks global license accord with Sanofi
19 April 2025
Pharmaceutical
FDA limits pharma staff serving on advisory committees
19 April 2025
Biotechnology
uniQure rockets on FDA Breakthrough status for AMT-130
18 April 2025
Pharmaceutical
Trump's executive order could help innovation, but range of scenarios still open
18 April 2025
Biotechnology
Eylea HD injection 8mg sBLA accepted for FDA Priority Review
18 April 2025
Biotechnology
Neurizon strengthens leadership team
18 April 2025

Company Spotlight

A biopharmaceutical company focused on developing next-in-class inflammatory disease medicines.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze